Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies
- DOI
- 10.1136/rmdopen-2025-006174
- Published
- 2026-01
- Container
- RMD Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2025-006174,
title = {Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies},
author = {Philip J Mease and Joseph F Merola and Marina Magrey and Peter Nash and Denis Poddubnyy and Mark Lebwohl and Rajan Bajracharya and Barbara Ink and Alexander Marten and Myriam Manente and Luke Peterson and Katy White and Lianne S Gensler},
year = {2026},
journal = {RMD Open},
doi = {10.1136/rmdopen-2025-006174},
url = {https://doi.org/10.1136/rmdopen-2025-006174}
}RIS
TY - JOUR TI - Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies AU - Philip J Mease AU - Joseph F Merola AU - Marina Magrey AU - Peter Nash AU - Denis Poddubnyy AU - Mark Lebwohl AU - Rajan Bajracharya AU - Barbara Ink AU - Alexander Marten AU - Myriam Manente AU - Luke Peterson AU - Katy White AU - Lianne S Gensler PY - 2026 JO - RMD Open DO - 10.1136/rmdopen-2025-006174 UR - https://doi.org/10.1136/rmdopen-2025-006174 ER -
APA
Mease, P. J., Merola, J. F., Magrey, M., Nash, P., Poddubnyy, D., Lebwohl, M., Bajracharya, R., Ink, B., Marten, A., Manente, M., Peterson, L., White, K., & Gensler, L. S. (2026). Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies. RMD Open. https://doi.org/10.1136/rmdopen-2025-006174
Source records
- crossref · retrieved 2026-09-25T02:43:26.349Z